EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta

Sima Stroganov iD, Talia Harris, Liat Fellus-Alyagor, Lital Ben Moyal, Romina Plitman Mayo, Ofra Golani iD, Dana Hirsch, Shifra Ben-Dor iD, Alexander Brandis, Tevie Mehlman, Michal Kovo, Tal Biron-Shental und 2 weitere

eLife · 2024

DOI: 10.7554/elife.82631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Sima Stroganov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Placenta, Fetal Growth Retardation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Minerva Foundation, Weizmann Institute of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fetal growth restriction (FGR) is a pregnancy complication in which a newborn fails to achieve its growth potential, increasing the risk of perinatal morbidity and mortality. Chronic maternal gestational hypoxia, as well as placental insufficiency are associated with increased FGR incidence; however, the molecular mechanisms underlying FGR remain unknown.

Methods

Pregnant mice were subjected to acute or chronic hypoxia (12.5% O 2 ) resulting in reduced fetal weight. Placenta oxygen transport was assessed by blood oxygenation level dependent (BOLD) contrast magnetic resonance imaging (MRI). The placentae were analyzed via immunohistochemistry and in situ hybridization. Human placentae were selected from FGR and matched controls and analyzed by immunohistochemistry (IHC). Maternal and cord sera were analyzed by mass spectrometry.

Results

We show that murine acute and chronic gestational hypoxia recapitulates FGR phenotype and affects placental structure and morphology. Gestational hypoxia decreased labyrinth area, increased the incidence of red blood cells (RBCs) in the labyrinth while expanding the placental spiral arteries (SpA) diameter. Hypoxic placentae exhibited higher hemoglobin-oxygen affinity compared to the control. Placental abundance of Bisphosphoglycerate mutase (BPGM) was upregulated in the syncytiotrophoblast and spiral artery trophoblast cells (SpA TGCs) in the murine gestational hypoxia groups compared to the control. Hif1α levels were higher in the acute hypoxia group compared to the control. In contrast, human FGR placentae exhibited reduced BPGM levels in the syncytiotrophoblast layer compared to placentae from healthy uncomplicated pregnancies. Levels of 2,3 BPG, the product of BPGM, were lower in cord serum of human FGR placentae compared to control. Polar expression of BPGM was found in both human and mouse placentae syncytiotrophoblast, with higher expression facing the maternal circulation. Moreover, in the murine SpA TGCs expression of BPGM was concentrated exclusively in the apical cell side, in direct proximity to the maternal circulation.

Conclusions

This study suggests a possible involvement of placental BPGM in maternal-fetal oxygen transfer, and in the pathophysiology of FGR. Funding: This work was supported by the Weizmann Krenter Foundation and the Weizmann – Ichilov (Tel Aviv Sourasky Medical Center) Collaborative Grant in Biomedical Research, by the Minerva Foundation, by the ISF KillCorona grant 3777/19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaFetal Growth RetardationHumansPregnancyFemaleMiceAnimalsBisphosphoglycerate MutaseTrophoblastsHypoxiaOxygen

Stichwörter der Autor:innen

2,3 BPGBPGMMRIbiochemistrychemical biologydevelopmental biologyhumanhypoxiamouseplacentapregnancy

Substanzen

Bisphosphoglycerate MutaseOxygen

Autor:innen und Institutionen

  • Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Chemical Research Support Weizmann Institute of Science, Rehovot, Israel.
  • Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
  • Life Science Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • OBGYN, Meir Medical Center, Kfar Saba, Israel.
  • Tel Aviv University, School of Medicine, Tel Aviv, Israel.

ORCID-Profile: Sima Stroganov, Ofra Golani, Shifra Ben-Dor, Michal Neeman

Förderung

  • Israel Science Foundation
  • Minerva Foundation
  • Weizmann Institute of Science

Zitieren

APA

Stroganov, S., Harris, T., Fellus-Alyagor, L., Ben Moyal, L., Plitman Mayo, R., Golani, O., Hirsch, D., Ben-Dor, S., Brandis, A., Mehlman, T., Kovo, M., Biron-Shental, T., Dekel, N., & Neeman, M. (2024). The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta. eLife. https://doi.org/10.7554/elife.82631

Vancouver

Stroganov S, Harris T, Fellus-Alyagor L, Ben Moyal L, Plitman Mayo R, Golani O, et al. The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta. eLife. 2024. doi:10.7554/elife.82631

BibTeX
@article{Stroganov2024,
  author = {Stroganov, Sima and Harris, Talia and Fellus-Alyagor, Liat and Ben Moyal, Lital and Plitman Mayo, Romina and Golani, Ofra and Hirsch, Dana and Ben-Dor, Shifra and Brandis, Alexander and Mehlman, Tevie and Kovo, Michal and Biron-Shental, Tal and Dekel, Nava and Neeman, Michal},
  title = {The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.82631}
}
Kostenlos starten →